MD, PhD (Habil), FRANZCP
Paul Amminger is a Professorial Research Fellow at Orygen and also Professor of Youth Mental Health at the Centre for Youth Mental Health, The University of Melbourne.
His research spans traditional high-risk research in schizophrenia to cutting-edge intervention studies in the onset phase of psychosis and affective disorders.
Paul has pioneered indicated prevention using omega-3 fatty acids in young people at ultra high risk of developing psychosis. This research has been has been called a landmark study for early intervention in psychosis.
Over the past 15 years, he has conducted research and led clinical and research teams at Vienna’s Medical University and Orygen, with a focus on translating research into practice.
Read more about Paul's work in his Find an Expert profile on the University of Melbourne's website.
Neurobiology, neuroprotection, low-risk interventions, ultra high risk for psychosis.